Increase/Decrease in Cash: The total change in cash for the company over the given period.
Synaptogenix, Inc. (SNPX) had Increase/Decrease in Cash of $-11.01M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-5.66M |
|
-- |
|
-- |
|
$2.18M |
|
$-2.18M |
|
$-3.37M |
|
$-5.55M |
|
$-3.10M |
|
$-5.55M |
|
$-5.55M |
|
$-5.55M |
|
$-3.10M |
|
$-2.18M |
|
$-2.18M |
|
1.23M |
|
1.23M |
|
$-4.82 |
|
$-4.82 |
|
| Balance Sheet Financials | |
$17.72M |
|
$0.01M |
|
$0.01M |
|
$17.73M |
|
$1.01M |
|
-- |
|
$9.94M |
|
$10.96M |
|
$5.86M |
|
$6.78M |
|
$6.78M |
|
1.36M |
|
| Cash Flow Statement Financials | |
$-4.88M |
|
$-1.00M |
|
$-5.12M |
|
$28.66M |
|
$17.66M |
|
|
Increase/Decrease in Cash |
$-11.01M |
$0.14M |
|
-- |
|
$-0.95M |
|
| Fundamental Metrics & Ratios | |
17.47 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.88M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-94.59% |
|
-81.85% |
|
-31.28% |
|
-81.85% |
|
$4.99 |
|
$-3.96 |
|
$-3.96 |
|